Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Protection certificate |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 12 2015 000 034.7 |
| Use | VZ | Medicinal products |
95 | Product name | TIEZ | CYRAMZA - Ramucirumab |
54 | Title of basic patent | TIGZ | KDR-spezifische menschliche Antikörper und ihre Verwendung |
51 | IPC main class | ICM (ICMV) | A61K 39/395 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61P 35/00 (2006.01), C07K 16/28 (2006.01) |
94 | Start of term of protection | LB | Mar 5, 2023 |
94 | End of term of protection | LE | Mar 4, 2028 |
22 | DE application date | DAT | May 7, 2015 |
| Date of publication of application for a certificate | OT | Jul 9, 2015 |
| Date of publication of grant of certificate | PET | Mar 23, 2023 |
71/73 | Applicant/owner | INH | ImClone LLC, 1209 Orange Street, 19801 Wilmington, DE, US |
74 | Representative | VTR | Office Freylinger S.A., Strassen, LU |
| Address for service | | OFFICE FREYLINGER S.A., 8010 Strassen, LU |
| Due date | FT FG | Mar 31, 2026 Annual fee for the 24th year
Patent fees |
| Patent division in charge | | 44 |
68 | DE file number of basic patent | GAKZ | 603 37 262.7 |
68 | EP file number of basic patent | GEAKZ | 07 02 3361.4 |
43 | Date of first publication | EVT | Jul 9, 2015 |
92 92 92
| Domestic authorisation | GIS GIN GIT
| Europäische Kommission EU/1/14/957 2014-12-19
|
93 93 93 93
| EU authorisation | GES GEC GEN GET
| Europäische Kommission EU EU/1/14/957 2014-12-19
|
| Date of the first transfer into DPMAregister | EREGT | Jul 9, 2015 |
| Date of the (most recent) update in DPMAregister | REGT | Feb 28, 2025 (Show all update days)(Hide all update days)- Feb 28, 2025
- Aug 14, 2024
- St.36: changed (technical change)
- Feb 29, 2024; Mar 7, 2023; Mar 1, 2023; Feb 15, 2023; Dec 2, 2022; Dec 7, 2019; Jul 16, 2019; Aug 28, 2018; Jan 24, 2018; Jul 11, 2015
- Historical data not available for this/these date(s)
- Jul 9, 2015
- Date of the first transfer into DPMAregister
|